Antonijevic Irina 4

What Happened
Irina Antonijevic, a director of Biohaven Ltd. (BHVN), received a derivative award on April 28, 2026 covering 68,693 shares. The Form 4 reports the transaction as an award/grant (code A) at $0.00, indicating a stock option-style award rather than a cash purchase. No cash changed hands at grant; the award becomes an economic interest only if and when it vests and is exercised according to the plan.

Key Details

• Transaction date: 2026-04-28; Form 4 filed 2026-04-30 (timely filing).
• Transaction type/code: Grant/Award (A); reported price: $0.00; amount: 68,693 shares (derivative).
• Vesting: Per footnote, the options vest in full on the earlier of (a) April 28, 2027 or (b) the 2027 Annual Meeting of Shareholders, subject to continuous service (Footnote F1).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing accession: 0001926476-26-000002.

Context
This was a grants/award of stock options (a retention/incentive award) rather than an open-market buy or sale. The award does not represent immediately owned common shares — value accrues only if the options vest and any exercise/holding conditions are met. For details on strike price, exercise terms, or plan documents, check the full Form 4 and the company’s equity plan disclosures.